The trajectory of Sildenafil presents a complex picture for those considering investment. While the initial release generated substantial returns, the end of its patent opened the floodgates to generic versions, dramatically eroding sales. This poses more info a unique risk for drug manufacturers depending on related blockbuster offerings, suggesti

The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. At first a blockbuster drug, producing billions in income, its patent expiration created a flood of knock-off medications, significantly impacting its market share . While specific businesses may try to capitalize on related treatments , the existin